The c-erbB-2/neu proto-oncogene in human pituitary tumours

Clinical Endocrinology

Volumn 46, Issue 5, 1997, Pages 599-606

  Ezzat, Shereen ^a,b   Zheng, Lei ^a   Smyth, Harley S ^a   Asa, Sylvia L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE NEU; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030791088     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.1921003.x     Document Type: Article

References (49)

1. Aasland, R., Lillehaug, J.R., Male, R., Josendal, O., Varhaug, J.E. & Kleppe, K. (1988) Expression of oncogenes in thyroid tumours: coexpression of c-erbB2/neu and c-erbB. British Journal of Cancer, 57, 358-363.
2. Akslen, L.A. & Varhaug, J.E. (1995) Oncoproteins and tumor progression in papillary thyroid. Cancer, 76, 1643-1654.
3. Alexander, J.M., Biller, B.M.K., Bikkal, H., Zervas, N.T., Arnold, A. & Klibanski, A. (1990) Clinically nonfunctioning pituitary tumors are monoclonal in origin. Journal of Clinical Investigation, 86, 336-340.
4. Alvaro, V., Lévy, L., Dubray, C., Roche, A., Peillon, F., Quérat, B. & Joubert, D. (1993) Invasive human pituitary tumors express a point-mutated α-protein kinase-C. Journal of Clinical Endocrinology and Metabolism, 77, 1125-1129.
5. Asa, S. L., Puy, L.A., Lew, A.M., Sundmark, V.C. & Elsholtz, H.P. (1993) Cell type-specific expression of the pituitary transcription activator Pit-1 in the human pituitary and pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 77, 1275-1280.
6. Asa, S.L., Bamberger, A-M., Cao, B., Wong, M., Parker, K.L. & Ezzat, S. (1996) The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. Journal of Clinical Endocrinology and Metabolism, 81, 2165-2170.
7. Beerli, R.R. & Hynes, N.E. (1996) Epidermal growth factor-related peptides activate distinct subsets of ErbB receptors and differ in their biological activities. Journal of Biological Chemistry, 271, 6071-6076.
8. Bystrom, C., Larsson, C., Blomberg, C., Sandelin, K. & Falkmer, E. (1990) Localization of the MEN-1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proceedings of the National Academy of Sciences USA, 87, 1968-1972.
9. Busmanis, I., Feleppa, F., Jones, A., McGrath, K.M., Reed, R., Collins, J., Russell, I. & Begley, C.G. (1994) Analysis of cerbB2 expression using a panel of 6 commercially available antibodies. Pathology, 26, 261-267.
10. Coussens, L., Yang-Feng, T.L., Liao, Y-C., Chen, E., Gray, A., McGrath, J., Seeburg, P.H., Libermann, T.A., Schlessinger, J., Francke, U., Levinson, A. & Ullrich, A. (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science, 230, 1132-1139.
11. Cryns, V.L., Alexander, J.M., Klibanski, A. & Arnold, A. (1993) The retinoblastoma gene in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism. 77, 644-646.
12. Dougall, W.C., Quan, X., Peterson, N.C., Miller, M.J., Samanta, A. & Greene, M.I. (1994) The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies. Oncogene, 9, 2109-2123.
13. Ekstrand, A.J., Sugawa, N., James, C.D. & Collins, V.P. (1992) Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proceedings of the National Academy of Sciences USA, 89, 4309-4313.
14. Ellis, C., Moran, M., McCormick, F. & Pawson, T. (1990) Phosphorylation of GAP and GAP-associated proteins by transforming and nitrogenic kinase Nature, 343, 377-381.
15. Evers, B.M., Rady, P.L., Tyring, S.K., Sanchez, R.L., Rajaraman, S., Townsend Jr, C.M. & Thompson, J.C. (1992) Amplification of the HER-2/neu protooncogene in human endocrine tumors. Surgery, 112, 211-218.
16. Evers, B.M., Rady, P.L., Sandoval, K., Arany, I., Tyring, S.K., Sanchez, R.L., Nealon, W.H., Townsend Jr, C.M. & Thompson, J.C. (1994) Gastrinomas demonstrat amplification of the HER-2/neu protooncogene. Annals of Surgery, 219, 596-604.
17. Ezzat, S., Walpola, I.A., Ramyar, L., Smyth, H.S. & Asa, S.L. (1995) Membrane-anchored expression of transforming growth factor-α in human pituitary adenoma cells. Journal of Clinical Endocrinology and Metabolism, 80, 534-539.
18. Ezzat, S. & Melmed, S. (1990) The role of growth factors in the pituitary. Journal of Endocrinological Investigation, 13, 691-698.
19. Frye, R.A., Benz, C.C. & Liu, E. (1989) Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene, 4, 1153-1157.
20. Goldman, R., Levy, R.B., Peles, E. & Yarden, Y. (1990) Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochemical Journal, 29, 11024-11028.
21. Guy, C.T., Cardiff, R.D. & Muller, W.J. (1996) Activated neu induces rapid tumor progression. Journal of Biological Chemistry, 271, 7673-7678.
22. Herman, V., Fagin, J., Gonsky, R., Kovacs, K. & Melmed, S. (1990) Clonal origin of pituitary adenomas. Journal of Clinical Endocrinology and Metabolism, 71, 1427-1433.
23. Herman, V., Drazin, N.Z., Gonsky, R. & Melmed, S. (1993) Molecular screening of pituitary adenomas for gene mutations and rearrangements. Journal of Clinical Endocrinology and Metabolism, 77, 50-55.
24. HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proceedings of the National Academy of Sciences USA, 84, 7159-7163.
25. Karga, H.J., Alexander, J.M., Hedley-White, E.T., Klibanski, A. & Jameson, J.L. (1992) Ras mutations in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 74, 914-919.
26. Kokai, Y., Meyers, J.N., Wada, T., Brown, V.I., Levea, C.M., Davis, J.G., Dobashi, J.G. & Greene, M.I. (1989) Synergistic interaction of p185c-neu and EGF receptor leads to transformation of rodent fibroblasts Cell, 58, 287-292.
27. Lee, K-F., Simon, H., Chen, H., Bates, B., Hung, M-C. & Hauser, C. (1995) Requirement for neuroregulin receptor erbB2 in neural and cardiac development. Nature (London), 378, 394-398.
28. Lemoine, N.R., Staddon, S., Dickson, C., Bames, D.M. & Cullick, W.J. (1990a) Absence of activating transmembrane mutations in the c-erbB-2 proto-oncogene in human breast cancer. Oncogene, 5, 237-239.
29. Lemoine, N.R., Wyllie, F.S., Lillehaug, J.R., Staddon, S.L., Hughes, C.M., Aasland, R., Shaw, J., Varhaug, J.E., Brown, C.L., Gullick, W.J. & Wynford-Thomas, D. (1990b) Absence of abnormalities of the c-erbB-1 and c-erbB-2 proto-oncogene in human thyroid neoplasia. European Journal of Cancer, 26, 777-779.
30. LeRiche, V., Asa, S.L. & Ezzat, S. (1996) Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness. Journal of Clinical Endocrinology and Metabolism, 81, 656-662.
31. Lyons, J., Landis, C.A., Harsh, G., Vallar, L., Grünewald, K., Feichtinger, H., Duh, Q-Y., Clark, O.H., Kawasaki, E., Bourne, H.R. & McCormick, F. (1990) Two G protein oncogenes in human endocrine tumors. Science, 249, 655-659.
32. Marchionni, M.A., Goodearl, A.D.J., Chen, M.S., Bermingham-McDonogh, O., Kirk, C., Hendricks, M., Danehy, F., Misumi, D., Sudhalter, J., Kobayashi, K., Wroblewski, D., Lynch, C., Baldassare, M., Hiles, I., Davis, J.B., Hsuan, J.J., Totty, N.F., Otsu, M., McBurney, R.N., Waterfield, M.D., Stroobant, P. & Gwynne, D. (1993) Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature (London), 362, 312-318.
33. McAndrew, J., Paterson, A.J., Asa, S.L., McCarthy, K.J. & Kudlow, J.E. (1995) Targeting of transforming growth factor-α expression to pituitary luctotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology, 136, 4479-4488.
34. Muthuswamy, S.K. & Muller, W.J. (1995) Direct and specific interaction of c-Src with Neu is involved in signalling by the epidermal growth factor receptor. Oncogene, 11, 271-279.
35. erbB4, a fourth member of the epidermal growth factor receptor family. Proceedings of the National Academy of Sciences USA, 90, 1746-1750.
36. Qian, X., Levea, C.M., Freeman, J.K., Dougall, W.C. & Greene, M.I. (1994) Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu; a mechanism of interreceptor kinase activation and transphosphorylation. Proceedings of the National Academy of Sciences USA, 91, 1500-1504.
37. Schlegel, J., Merdes, A., Stumm, G., Albert, F.K., Forsting, M., Hynes, N. & Kiessling, M. (1994) Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. International Journal of Cancer, 56, 72-77.
38. Seidman, J.D., Frisman, D.M. & Norris, H.J. (1992) Expression of the her-2/neu proto-oncogene in serous ovarian neoplasms. Cancer, 70, 28577-28609.
39. Simpson, B.J.B., Weatherill, J., Miler, E.P., Lessells, A.M., Langdon, S.P. & Miller, W.R. (1995) c-erbB-3 protein expression in ovarian tumours. British Journal of Cancer, 71, 758-762.
40. Sumi, T., Stefaneanu, L., Kovacs, K., Asa, S.L. & Rindi, G. (1993) Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocrine Pathology, 4, 95-99.
41. Thodou, E., Ramyar, L., Cohen, A.I., Singer, W. & Asa, S.L. (1995) A serum-free system for primary cultures of human pituitary adenomas. Endocrine Pathology, 6, 289-299.
42. N α-gene in nonfunctioning pituitary tumors. Journal of Clinical Endocrinology and Metabolism, 77, 765-769.
43. Vallar, L., Spada, A. & Giannattasio, G. (1987) Altered G, and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature (London), 330, 566-568.
44. Webster, J., Ham, J., Bevan, J.S. & Scanlon, M.F. (1989) Growth factors and pituitary tumors. Trends in Endocrinology and Metabolism, 1, 95-98.
45. Woloschak, M., Roberts, J.L. & Post, K.D. (1994) Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer (Philadelphia), 74, 693-696.
46. Wong, A.J., Ruppert, J.M., Bigner, S.H., Grzeschik, C.H., Humphrey, P.A., Bigner, D.S. & Vogelstein, B. (1992) Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proceedings of the National Academy of Sciences USA, 89, 2965-2969.
47. Xie, Y., Li, K. & Hung, M-C. (1995) Tyrosine phosphorylation of She proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu. Oncogene, 10, 2409-2413.
48. Zafar, M., Ezzat, S., Ramyar, L., Pan, N., Smyth, H.S. & Asa, S.L. (1995) Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. Journal of Clinical Endocrinology and Metabolism, 80, 3621-3627.
49. Zhu, J., Leon, S.P., Beggs, A.H., Busque, L., Gilliland, D.G. & Black, P.M. (1994) Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. Journal of Clinical Endocrinology and Metabolism, 78, 922-927.